VEGF-A decreases the adhesive interaction between lymphocytes and tumor vascular endothelial cells, and reduces TIL penetration through deregulation of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion-molecule-1 (VCAM-1) [43]. Here, VCAM1 is linked to neoplasm.